2007 Annual Meeting | Behavioral Neurology: Issues in Cognitive Impairment

Date Friday 05/04/07

Time 01:15 PM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type PM Half-Day Course

Director(s) John Hart, MD

Topic(s)

Learning Objectives Participants should become familiar with recent findings in cognitive neurology, be able to apply them to the differential diagnoses and workup of cognitive disorders, and obtain an update on new findings in the field.

CME Available No CME available

Core Competencies Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident

Event Timeline
01:15 PM - 02:00 PM		Cognitive Effects of Antiepileptic Drugs Kimford J. Meador, MD, FAAN
02:00 PM - 02:45 PM		Memory Reisa A. Sperling, MD
02:45 PM - 03:30 PM		Language Jeffrey Binder, MD
03:30 PM - 04:00 PM		Break
04:00 PM - 04:45 PM		Spatial Language Anjan Chatterjee, MD, FAAN
04:45 PM - 05:00 PM		Questions and Answers John Hart, MD

Faculty Disclosures
Kimford J. Meador, MD, FAAN	The institution of Dr. Meador has received research support from NIH. The institution of Dr. Meador has received research support from Eisai. The institution of Dr. Meador has received research support from Medtronics. The institution of Dr. Meador has received research support from The Epilepsy Consortium.
John Hart, MD	The institution of Dr. Hart has received research support from Department of Defense.
Jeffrey Binder, MD	No disclosure on file
Reisa A. Sperling, MD	Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acumen. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nervgen. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oligomerix. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vaxxinity. An immediate family member of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. An immediate family member of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Dr. Sperling has received research support from Eli Lilly. The institution of Dr. Sperling has received research support from Eisai. The institution of Dr. Sperling has received research support from NIH.
Anjan Chatterjee, MD, FAAN	The institution of Dr. Chatterjee has received research support from Templeton Religion Trust. The institution of Dr. Chatterjee has received research support from Henry Jackson Foundation.

��ɫ��

��ɫ��